Drugplain

PROCYSBI 75 mg/1

Cysteamine bitartrate · GRANULE, DELAYED RELEASE · Horizon Therapeutics USA, Inc.

No Recall History
Plain English

PROCYSBI is a granule, delayed release containing cysteamine bitartrate at 75 mg/1, taken oral. Manufactured by Horizon Therapeutics USA, Inc..

Key Facts

Brand Name
PROCYSBI
Generic Name
Cysteamine bitartrate
NDC Code (Product)
75987-140
Manufacturer
Horizon Therapeutics USA, Inc.
Strength
75 mg/1
Dosage Form
GRANULE, DELAYED RELEASE
Route
ORAL
Marketing Status
Application #
NDA213491
Marketing Start
02/14/2020

Recall History

No Recall History

Frequently Asked Questions

What is PROCYSBI used for?

PROCYSBI contains Cysteamine bitartrate. It is a granule, delayed release taken oral. Consult your doctor for specific uses.

Is PROCYSBI a controlled substance?

PROCYSBI is not classified as a controlled substance by the DEA.

What is the generic name for PROCYSBI?

The generic name for PROCYSBI is Cysteamine bitartrate. There are 2 other brand versions of Cysteamine bitartrate.

What is the NDC code for PROCYSBI 75 mg/1?

The NDC (National Drug Code) for PROCYSBI 75 mg/1 is 75987-140, listed by Horizon Therapeutics USA, Inc..

Product NDC

75987-140

Package NDC

75987-140-13

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)